DefinitionThis section has been translated automatically.
EtiopathogenesisThis section has been translated automatically.
Congenital or acquired lymphatic drainage disorders. Partial immunodeficiency of the organism against streptococcal antigen.
The following anamnestic and clinical data are associated with an increased risk of recurrence:
You might also be interested in
Clinical featuresThis section has been translated automatically.
Complication(s)This section has been translated automatically.
TherapyThis section has been translated automatically.
- In the acute stage antibiotics. S.u. Erysipelas.
- In case of underlying or secondary lymph drainage disorders, compression therapy with elastic short-stretch bandages as well as manual and, if necessary, additional intermittent lymphatic drainage by apparatus (30 min./day).
Notice!Lymphatic drainage in case of inflammation due to danger of sepsis only under antibiotic protection!
- Satisfactory long-term therapy successes are achieved by intermittent penicillin therapy (several studies with evidence level up to IIa). Therapy schedule 1: Penicillin G every 3 months (10 million IU/day penicillin i.v. over 10 days); treatment period: 1 year.
- Therapy schedule 2: Penicillin V 250mg 2x/day p.o. for a period of 6 months. In this study (123 patients) the risk of recurrence was reduced by about 50%.
- In case of penicillin intolerance use Erythromycin 2 times/day 1 g i.v. for 10 days or Cephalosporins ( Ceftriaxon 2g i.v./day).
LiteratureThis section has been translated automatically.
- Chlebicki MPet al. (2014) Recurrent cellulitis: risk factors, etiology,pathogenesis and treatment. Curr Infect Dis Rep 16:422
Inghammar M et al (2014) Recurrent erysipelas--risk factors andclinical
presentation. BMC Infect Dis 14: 270
- McNamara DR et al (2007) A predictive model of recurrent lower extremity cellulitis in a population-based cohort. Arch Internal Med 167: 709-715
- Thomas K et al(2012) Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network's PATCH II trial. Br J Dermatol 166:169-178.
Outgoing links (13)Antibiotics; Ceftriaxone; Chronic venous insufficiency (overview); Compression therapy; Congestive dermatitis; Erysipelas; Erythromycin; Inflammatory elephantiasis; Lymph drainage; Lymphedema (overview); ... Show all
Please ask your physician for a reliable diagnosis. This website is only meant as a reference.